Meyka Pro banner
Lung Fung Group Holdings Limited

Lung Fung Group Holdings Limited (2290.HK) Stock Overview

Explore Lung Fung Group Holdings Limited’s financial performance, market position, analyst ratings, and future outlook.

2290.HKHKSE
HealthcareMedical - Distribution
HK$3.71
HK$0.03(0.80%)
Hong Kong Market opens in 2h 2m

Lung Fung Group Holdings Limited (2290.HK)

Meyka AI Score

Z

Key Financials

Market Cap1.9B
P/E RatioN/A
EPS (TTM)$170.43
ROEN/A
Fundamental Analysis

AI Price Forecasts

1 Month$4.91
3 Months$11.93
1 Year TargetN/A

2290.HK Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Lung Fung Group Holdings Limited (2290.HK) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 64.36, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of N/A and a market capitalization of 1.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.80%
5-Day Change
1.09%
1-Month Change
74.18%
3-Month Change
32.03%
6-Month Change
32.03%
Year-to-Date (YTD) Change
32.03%
1-Year Change
32.03%
3-Year Change
32.03%
5-Year Change
32.03%
All-Time (Max) Change
32.03%

Contact Information

NaN
5/F, Lung Fung Group Centre, Fanling, NT, NaN

Company Facts

7,860 Employees
IPO DateJun 5, 2026
CountryHK
Actively Trading

Frequently Asked Questions